J.INC.

INTERMEDIATES LIST
1   139404-48-1 Tiotropium monohydrate
2   28319-72-4 Eplerenone
3 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-Naphthalenone, (Tetralone compound) 79560-19-3 Sertraline Hydrochloride
4 4-Chloro-2,3-dimethyl pyridine-1-oxide 59886-90-7 Rabeprazole
5 Benzyl, DL-2beta-3a beta 7-a alpha octahydroindole-2-carbozylate hydrochloride   Trandolapril
6 Cis-[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)-1,3 -dioxolan-4-yl] methyl p-Toluenesulfonate.
Terconazole,Itraconazole
7 (-)-2,3-O-Isopropylidene-1,1,4,4-tetraphenyl-L-threitol[(4R,5R)-2,2-Dimethyl-α,α,α’,α’-tetraphenyldioxolane-4,5-dimethanol (Chiral) 93379-48-7 Chiral Auxillary for asymmetic compounds
8 (-)-4-[4-(Dimethylamino)-1-(4’-fluorophenyl)-1-hydroxy-1-butyl]-3-(hydroxymethyl)benzonitrile,Tosyltartaric acid salt   Escitalopram Oxalate
9 (-)-6-(4-Aminophenyl)-4, 5-dihydro-5-methyl-3(2H)-pyridazinone   Levosimendan
10 (-)-Di-O-O’-p-toluyl-D-tartaric acid ( Chiral ) Also known as Di-p-Toluoyl -L-Tartaric Acid (Monohydrate) 32634-66-5 Amoxicillin, Cephatrizine, Chloramphenicol,Reagent for chiral resolution of amino compounds
11 (-)-O,O’Dibenzoyl-L-tartaric acid ( Chiral ) Also Known as Di-Benzoyl -L-Tartaric Acid (Monohydrate) 62708-56-9 Amoxicillin, Cephatrizine, Chloramphenicol,Reagent for chiral resolution of amino compounds
12 (-)-Trans-4R-(4-Fluorophenyl)-3S-hydroxymethyl-N-methylpiperidine 105812-81-5 Paroxetine
13 (+)-Dimethyl L-tartarate ( Chiral ) 608-68-4 Resolution Of (API ) Chloramphenicol
15 (+)-Methyl-alpha-(2-Thienylethamino) (2-Chlorophenyl) Acetate Hydrochloride 141109-19-5 Clopidogrel Bisulphate
16 (1,3-Butanedione-4, 4,4-trifluoro 1-(4-Methylphenyl)-1-P-tolyl 720-94-5 Celecoxib
17 (1,3-Oxithiolane-Carboxylic Acid 5-(4-Amino-2-Oxo-1(2H)-Pyrimidinyl--5methyl-2-(1methylethyl)Cyclohexylester[1R-[1-A(2S*,5R*),2B,5B]] 147126-73-6 Lamivudine
18 (1-Methyl-4-piperidinyl) {3[2-(3-chlorophenyl) ethyl ]2-pyridinyl} methanone 130642-50-1 Loratadine
19 (1-naphthyl-methyl)methylamine 98% liquid 42882-31-5 Terbinafine HCL
20 (1R, 2S, 5R)-menthyl-5(s)-cytosin-1-yl-1,3-oxathiolane-2R-carboxylate 73590-85-9 Lamivudine
21 (1R, 2S, 5R)-menthyl-5R-hydroxy-1,3-oxathiolane-2R-carboxylate   Lamivudine
22 (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-amino-2-oxo-2H-5-fluoro-pyrimidin-1-yl)-[1-3]oxathiolane-2-carboxylic acid 147126-75-8 Emtricitabine
23 (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid 147027-10-9 Lamivudine
24 (1R,2S,5R)-menthyl-5(R)Acetoxy-1,3-oxathiolane-2(R)-Carboxylate   Lamivudine
25 (1R,2S,5R)-Menthyl-5R-Acetxy-1,3-Oxathiolane-2R-Carrboxylate[1R[1a((2S,5R)),2B,5a]] 147126-67-8 Lamivudine
26 (1R,2S,SR)-menthyl-5(s)cystosine-1-yl) 1-3-oxathiolane-2R-carboxylate   Lamivudine
27 (1R,3R)-methyl 1-(benzo[d][1,3]dioxol-6-yl)-2-(2-chloroacetyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, Purity 99% min.   Tadalafil
28 (2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)- 1-(1H-1,2,4-triazol- 1-yl)-2- butanol hydrochloride   Voriconazole
29 (2R,3S/2S,3R)-3-(5-Fluoro-4-pyrimidinyl)-2-(2,4-difluorophenyl)- 1-(1H-1,2,4-triazol- 1-yl)-2- butanol   Voriconazole
30 (2R-trans)-4-(1,3-benzodioxol-5-yl)-1,2,3,4-tetrahydro-5H-pyrido[3,4-b]indole-2-carbolic acid methyl ester   Tadalafil
31 (2S)-(1-tetrahydro-pyrimid-2-only)-3-methyl-butanoic acid 192725-50-1 Lopinavir
32 (2s,3aS,7aS)-2- Carboxyoctahydroindole   Perindopril
33 (2S,3R)-1-chloro-3-[[(phenylmethoxy)carbonyl]amino]-4-(phenylthio)butan-2-ol 159878-02-1 Nelfinavir
34 (2S,3S)-(+)-3- hydroxy-2- (4- methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin- 4(5H)-one [ CIS- (+) -hydroxy lactam] 42399-49-5 Diltiazem
35 (2S,3S)-(+)-3-(2-aminophenylthio)-2-hydroxy-3- (41- methoxyphenyl)propionic acid [ D- (+) - Acid]   Diltiazem
36 (2S,3S,5S)-2-amino-3-hydroxy-5-(t-butyloxycarbonylamino-1,6-diphenyl-hexane succinic acid 144163-85-9 Ritonavir
37 (3S)N-tert-butyl-decahydro-3-isoquinolinecarboxamide 136466-81-1 Nelfinavir
38 (4-Sulfamoyl phenyl) hydrazine hydrochloride 27918-19-0 Celecoxib
39 (6R, 7R)-7-Amino-3-[(1-methyl-1-pyrrolidino)methyl]ceph-3-em-4-carboxylate hydriodic acid   Cefepime
40 (CIS)-4-Acetamidocyclopent-2-ene methyl acetate 61865-50-7 Abacavir
41 (DL)-2-Phenylglycine isopentyl ester Hydrochloride   Specialty Chemical
42 (E)Ethyl 4-(3,4-dimethoxyphenyl)-4-oxo-2-butenoate 80937-23-1 Specialty Chemical, API'S like Gaestrointestinal or Antiulcerative and drugs of cardiovascular system.
43 (E/Z) (4-2-Methyl-buten) 4-(2-benzyloxycarbonyolaminothiazol-4-yl)-4-carboxy-3-butyrate (Ceftibuten side chain)   Ceftibuten
44 (L) Prolinol (Chiral) 23356-96-9 Chiral Building Block, S.M. in a synthesis of Bemazopine ( Caclium Channel Blockers ) JMC-35, 2610 (1992 ) , TL - 26, 3783 (1985) 26, 3787 (1985)
45 (R)-(+)-2-Chloro propionic acid 7474-05-7 Fine Chemicals Synthesis
46 (R)-4-Benzyl-2-oxazolidinone ( Chiral ) 102029-44-7 Chiral Building Block
47 (R)-4-Isopropyl-2-oxazolidinone (Chiral) 95530-58-8 Chiral Synthesis of β-Lactams
48 (R)-4-Phenyl-2-oxazolidinone ( Chiral ) 90319-52-1 Synthesis of β-Lactams, Resolution & Pri-amines
49 (R)-Phenylalaninol ( Chiral ) 5267-64-1 Asymmetric Michael Reactions
50 (R)-Phenylglycinol ( Chiral ) 56613-80-0 Oxazulidine Derivatives
51 (R)-Tetrahydro-1-methyl-1,3-diphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxazoborole 112022-83-0 Ezetimibe
52 (R)-Valinol ( Chiral ) 4276-09-9 Synthesis of Oxuzolidin-2-one & its derivatives and synthesis of Himastatine (API)
53 (RS]–(+)–Methyl-α-[2-Thienylethylamine]–[2-Chrolo Phenyl] Acetate HCl Racemic compound Clopidogrel Sulfate
54 (S)-(-)Indoline-2-Carboxylic Acid 79815-20-6 Fine Chemicals Synthesis
55 (S)-(+)-(o-Chlorophenyl) glycine 141315-50-6 Clopidogrel Bisulphate
56 (S)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid   Quinapril
57 (S)-2-Amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole   Pramipexole
58 (S)-3-Hydroxy-gamma-butyrolactone 7331-52-4 Ezetimibe
59 (S)-4-(4-aminobenzyl)-2-oxazolidinone 152305-23-2 Zolmitriptan
60 (S)-4-(4-hydrazinobenzyl)-2-oxazolidinone 171550-12-2 Zolmitriptan
  Next >>
Intermediates Page: 1 2 3 4 5 6 7 8
PATENTS:
  • Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
  • Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1)
Mail us : info@j-inc.biz Home | Sitemap | Back to Intermediates